Can You Have Acanthosis Nigricans Without Diabetes?
Yes, acanthosis nigricans (AN) commonly occurs without diabetes and is most frequently associated with obesity and insulin resistance rather than diabetes itself.
Understanding the Relationship
Acanthosis nigricans is a dermatological marker of insulin resistance, not diabetes per se. The condition manifests as symmetric, hyperpigmented, velvety plaques typically in intertriginous areas (neck, axillae, groin). While AN is associated with metabolic dysfunction, the presence of AN does not equate to having diabetes 1, 2.
Primary Associations Beyond Diabetes
Obesity and insulin resistance are the most common causes of AN in clinical practice:
- Studies show AN prevalence of 17% in children and 21% in adults in primary care settings, with most cases related to obesity rather than established diabetes 3
- Among Cherokee Indians, 34.2% had AN while 47.2% had hyperinsulinemia, demonstrating that AN frequently occurs in the prediabetic/insulin-resistant state 4
- In obese women with hyperandrogenism, 5% exhibited AN with marked insulin resistance but were not diabetic 5
Multiple Etiologies of Acanthosis Nigricans
The American Diabetes Association guidelines 2, 6, 2 clearly outline that AN occurs in several distinct conditions:
Genetic/Syndromic causes:
- Type A insulin resistance syndrome (mutations in insulin receptor gene)
- Leprechaunism and Rabson-Mendenhall syndrome
- Various chromosomal abnormalities (Down syndrome, Klinefelter syndrome, Turner syndrome)
Endocrine disorders:
- Polycystic ovary syndrome (PCOS) - where 60-80% may have metabolic complications 7
- Cushing's syndrome
- Acromegaly
- Type B insulin resistance (anti-insulin receptor antibodies in autoimmune conditions like lupus) 2, 8
Malignancy-associated AN:
- Can be a paraneoplastic phenomenon, particularly with gastric adenocarcinoma 9
Drug-induced:
- Glucocorticoids, nicotinic acid, certain hormones 2
Clinical Implications
AN serves as a screening tool for insulin resistance and diabetes risk, not a diagnostic criterion for diabetes itself 10, 7. The 2021 ADA Standards of Care 1 list AN as a clinical condition associated with insulin resistance when screening for type 2 diabetes risk, alongside hypertension, dyslipidemia, and PCOS.
Key Clinical Points
- AN patients have increased risk for developing diabetes but may not currently have it 3
- The prevalence ratio for type 2 diabetes in patients with AN is 1.97 after controlling for other risk factors, but this still means most AN patients don't have diabetes 3
- In type 1 diabetes patients, AN presence correlates with being overweight/obese rather than insulin resistance per se 11
Practical Assessment
When encountering AN, evaluate for:
- BMI and waist circumference (obesity is present in ~84% of AN cases) 12
- Fasting glucose and insulin levels
- Lipid profile
- Blood pressure
- Family history of diabetes
- Signs of PCOS in women (virilization, enlarged cystic ovaries) 2, 6
- Medication history
- Signs of endocrinopathy or malignancy if clinically indicated
The severity of AN (using Burke grading system) correlates with BMI and waist-hip ratio but not necessarily with the degree of insulin resistance 12, emphasizing that AN reflects a complex interplay between insulin signaling, excess weight, and metabolic dysfunction rather than a simple diabetes marker 11.